Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?

MLA

Meiser, Bruno M., et al. “Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients?” Transplantation, vol. 78, no. 4, Aug. 2004, pp. 591–98. EBSCOhost, https://doi.org/10.1097/01.tp.0000129814.52456.25.

APA

Meiser, B. M., Groetzner, J., Kaczmarek, I., Landwehr, P., Müller, M., Jung, S., Uberfuhr, P., Fraunberger, P., Stempfle, H.-U., Weis, M., & Reichart, B. (2004). Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation, 78(4), 591–598. https://doi.org/10.1097/01.tp.0000129814.52456.25

Chicago

Meiser, Bruno M, Jan Groetzner, Ingo Kaczmarek, Peter Landwehr, Markus Müller, Sebastian Jung, Peter Uberfuhr, et al. 2004. “Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients?” Transplantation 78 (4): 591–98. doi:10.1097/01.tp.0000129814.52456.25.